日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Jascayd (nerandomilast): a novel PDE4B inhibitor for idiopathic pulmonary fibrosis

Jascayd（nerandomilast）：一种用于治疗特发性肺纤维化的新型PDE4B抑制剂

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000004290
Hujjat, Syeda Fadak Zahra; Chandani, Harshika Khaim; Chandani, Devya Khaim; Khan, Muhammad Saad; Mahmoud, Abubakr
特发性肺纤维化
发表日期：2026
文献求助 收藏

Olezarsen: FDA approval and clinical impact in familial chylomicronemia syndrome (FCS)

Olezarsen：FDA批准及其在家族性乳糜微粒血症（FCS）中的临床影响

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000003768
Khan, Muhammad Saad; Chandani, Devya Khaim; Siddiqui, Erum; Khalid, Maliha; Waafira, Aminath
发表日期：2025
文献求助 收藏

Metabolic miracle or misguided shift? Tirzepatide in the era of obstructive sleep apnea (OSA)

代谢奇迹还是误入歧途？替拉帕肽在阻塞性睡眠呼吸暂停（OSA）时代的应用

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000004135
Chandani, Devya Khaim; Chandani, Harshika Khaim; Khan, Muhammad Saad; Hujjat, Syeda Fadak Zahra; Waafira, Aminath
代谢
发表日期：2025
文献求助 收藏

Measles resurgence in Texas: a public health wake-up call

德克萨斯州麻疹疫情卷土重来：公共卫生领域的警钟

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000003849
Siddiqui, Erum; Khan, Muhammad Saad; Chandani, Devya Khaim; Khalid, Maliha; Waafira, Aminath
麻疹
发表日期：2025
文献求助 收藏

Harliku (nitisinone): first FDA-approved disease-modifying therapy for alkaptonuria

哈利库（尼替西酮）：首个获得FDA批准的用于治疗尿黑酸症的疾病修饰疗法

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000004033
Chandani, Harshika Khaim; Hujjat, Syeda Fadak Zahra; Chandani, Devya Khaim; Khan, Muhammad Saad; Mahmoud, Abubakr
发表日期：2025
文献求助 收藏

Bruton's tyrosine kinase inhibition in ITP: Wayrilz (rilzabrutinib) as a disease-modifying strategy

ITP 中的布鲁顿酪氨酸激酶抑制：Wayrilz（rilzabrutinib）作为一种疾病修饰策略

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000004164
Hujjat, Syeda Fadak Zahra; Chandani, Harshika Khaim; Khan, Muhammad Saad; Chandani, Devya Khaim; Mahmoud, Abubakr
信号转导
发表日期：2025
文献求助 收藏

Breaking barriers in HIV management: the rise of long-acting lenacapavir

突破艾滋病毒治疗的障碍：长效来那卡帕韦的兴起

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000003775
Chandani, Devya Khaim; Khan, Sahira; Chandani, Harshika Khaim; Khan, Muhammad Saad; Mahmoud, Abubakr
HIV
微生物学
发表日期：2025
文献求助 收藏

Assessment of safety of niraparib maintenance therapy in epithelial ovarian cancer: an updated systematic review and meta-analysis of randomized control trials

评估尼拉帕尼维持治疗在卵巢上皮癌中的安全性：一项更新的随机对照试验系统评价和荟萃分析

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000003186
Khan, Muhammad Saad; Khalid, Maliha; Farhan, Kanza; Chandani, Harshika Khaim; Ansari, Osaid Ahmed; Chandani, Devya Khaim; Khalid, Dua; Memon, Usama; Waafira, Aminath
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏